Taken together, our results indicate that the FGF2-dependent PI3K/Akt/mTOR and MAPK/ERK activation is involved in FGF2-induced E-cadherin down-regulation and cell invasion in ovarian cancer cells. The gene discussed is FGF2; the disease is ovarian carcinoma.